Seven Studies Just Proved We Can Reverse Functional Age

The final week of 2025 delivered a watershed moment for longevity science. Seven peer-reviewed publications and a landmark $292 million AI-driven biotech IPO signal that we have officially transitioned from merely slowing aging to actively reversing its functional deficits. This deep dive examines the four pillars now defining functional age reversal: zombie cell elimination, metabolic restoration through NAD+ therapy, autophagy activation via dietary intervention, and epigenetic reprogramming in humans. We break down Georgetown's senolytics research eliminating senescent cells, Cleveland Medical Center's NAD+ reversal of Alzheimer's pathology, the first human clinical trial measuring autophagy during fasting, and Life Biosciences' upcoming epigenetic reprogramming trials. Laboratory science has prepared for clinical translation. The financial markets have validated the approach. We are entering the era where functional age reversal transitions from speculative possibility to measurable clinical reality. Subscribe to Tomorrow Unveiled for insights into the technologies shaping our future. #LongevityScience #AgingReversal #NADTherapy #SenescentCells #Autophagy #BiologicalAge #HealthSpan #GeroScience #FunctionalMedicine #AIdrugDiscovery 📑 Chapters: 00:00:00 Intro 00:02:36 Zombie Cells Problem 00:05:35 Senolytic Treatments 00:10:19 Immune System Restoration 00:14:19 Metabolic Reversal Strategy 00:24:00 Clinical Translation Advances 00:28:30 Longevity Gap Challenge 00:33:40 Multimodal Treatment Approach 00:35:47 Future of Longevity Medicine